Skip to content
Aperlena
Free alerts

TED - Tenders Electronic Daily (Publications Office of the EU) verified 1 day ago Contract notice

Germany - Medicines - Medicinal products with the active ingredient Ebastine (ATC: R06AX22)

Original Deutschland - Arzneimittel - Arzneimittel mit dem Wirkstoff Ebastin (ATC: R06AX22)

Open Germany Sachsen-Anhalt Medical equipment & pharmaceuticals

Buyer AOK Sachsen - Anhalt

359 days left

Key facts

Closes
Competition
Open race
  1. Published
  2. Today
  3. Deadline open for 717 days
  4. Awarded pending
View the official notice Watch this tender
Add to calendar

If the deadline moves or the notice is corrected, we email you. Log in

The Aperlena Verdict

Open race

No supplier dominates: 12 different companies have won the last 13 comparable contracts from this buyer over 5 years. This is a genuinely open race.

Based on 13 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

The health insurer AOK Sachsen-Anhalt is concluding non-exclusive rebate contracts under Section 130a paragraph 8 SGB V for finished medicinal products containing the active ingredient ebastine (ATC: R06AX22) under an open-house model. With uniform contract terms and a uniform access procedure, every suitable and interested pharmaceutical company or grouping of pharmaceutical companies may join at any time and on equal conditions, without individual negotiations. Contracts start at the earliest on 1 December 2025 and last up to 24 months, ending on 30 November 2027. Participation documents and the contract are available on request and must be completed and signed in full.

Description

Gegenstand dieser Veröffentlichung ist der Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Fertigarzneimitteln mit dem Wirkstoff Ebastin (ATC: R06AX22) im Rahmen eines sogenannten "open-house-Modells". Unter Vorgabe einheitlicher Vertragskonditionen sowie eines einheitlichen Zugangsverfahrens wird allen geeigneten und interessierten pharmazeutischen Unternehmen oder Gemeinschaften pharmazeutischer Unternehmen der Abschluss bzw. Beitritt zu einem Rabattvertrag nach § 130a Abs. 8 SGB V zu den vorgenannten Wirkstoffen bzw. Arzneimitteln angeboten. Interessierte pharmazeutische Unternehmen können dazu bei der genannten Kontaktadresse die Teilnahmeunterlagen sowie den jeweiligen Vertrag anfordern. Voraussetzung für den Abschluss eines Vertrages ist, dass das interessierte pharmazeutische Unternehmen die angeforderten Teilnahmeunterlagen vollständig ausgefüllt und unterzeichnet. Abschluss nicht-exklusiver Rabattvereinbarungen gemäß § 130a Abs. 8 SGB V zu Fertigarzneimitteln mit dem Wirkstoff Ebastin (ATC: R06AX22) bei jederzeitiger Abschlussmöglichkeit im Rahmen eines sogenannten "open-house-Modells". Mit jedem pharmazeutischen Unternehmen, das die Teilnahmevoraussetzungen erfüllt, wird ein Vertrag abgeschlossen. Eine Exklusivität ist nicht gegeben. Der Beitritt bzw. der Vertragsabschluss kann jederzeit und zu den gleichen Bedingungen erfolgen. Individuelle Vertragsverhandlungen werden nicht durchgeführt. Der früheste Vertragsbeginn ist der 01.12.2025. Davon ausgehend beträgt die Vertragslaufzeit maximal 24 Monate. Der Vertrag endet am 30.11.2027 unabhängig von dem Beginn des Vertrages. Sollte die AOK Sachsen-Anhalt während der Vertragslaufzeit nach Maßgabe der einschlägigen vergaberechtlichen Vorschriften Exklusivverträge für die Wirkstoffe ausschreiben, werden die im Rahmen dieser Veröffentlichung geschlossenen Verträge entsprechend den vertraglichen Regelungen beendet. Bei der vorliegenden Veröffentlichung handelt es sich nicht um die Vergabe eines öffentlichen Auftrags im Sinne des § 103 GWB bzw. des Vergaberechts. Um ein weitestgehendes Maß an Transparenz für die beabsichtigten Vertragsabschlüsse zu gewährleisten, erfolgt die Veröffentlichung im Supplement zum Amtsblatt der Europäischen Union. In Ermangelung eines entsprechenden Veröffentlichungsformulars wird die Auftragsbekanntmachung genutzt. Die daraus resultierenden begrifflichen Vorgaben, wie bspw. die Verfahrensbezeichnung "offenes Verfahren", sind einzig der Nutzung dieses Bekanntmachungsformulars und der Veröffentlichungsplattform geschuldet. Eine weitere Bedeutung, insbesondere eine Unterwerfung unter vergaberechtliche Regelungen, soweit sie nicht aus rechtlichen Gründen verpflichtend sind, ist damit nicht verbunden.

Bid or no-bid?

Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.

  1. In your favour:

    Do we meet every eligibility criterion?

    Open procedure: any interested supplier may submit a bid.

    Above the EU threshold: open to companies from any EU country.

  2. Your call:

    Can we deliver this with the team we have?

    The register holds nothing on this. The official documents will.

  3. Your call:

    Do we have two comparable references?

    Comparable work is in Medical equipment & pharmaceuticals.

  4. In your favour:

    Is the deadline realistic for a proper offer?

    359 days left, 257 of them working days.

  5. Your call:

    Is there a margin at the likely winning price?

    This buyer usually awards this kind of contract for between €1 and €1.

  6. In your favour:

    Do we know this buyer?

    12 different companies won the last 13 comparable contracts.

Can I bid?

  • Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
  • The notice is written in German.
  • Certificates from another EU country? Check the equivalents on eCertis

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 day ago

View the official notice

What this buyer has paid before

Based on 13 comparable contracts this buyer awarded in this sector over the last 4 years.

Median award
€1
Middle half of past awards
€1 to €1

TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it has no mark on the scale. The official documents may state one.

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

The buyer

Full buyer profile

AOK Sachsen - Anhalt

Germany

notices in the register
151
awards
45
awarded in total
€3.5M

Who wins its contracts

Many suppliers
different companies won its awards
21
of the awards went to the three most frequent winners
24%
of its calls state an estimated value
0%

Based on 25 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
3.5
of those lots received a single tender
31%
of the awards went to companies based in another country
0%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.

Who usually wins this buyer's contracts in this sector

Company Wins Total awarded Last win
Novartis Pharma GmbH 2 Sep 2026
Bayer Vital GmbH 1 Sep 2026
Biotest GmbH & Co. KGaA 1 Sep 2026
CSL BEHRING GMBH 1 Sep 2026
GlaxoSmithKline GmbH & Co. KG 1 May 2026

Based on 13 awards with a linked company profile over the last 5 years.

98 open tenders right now

Market context

TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it cannot be placed among the open notices of its sector. The official documents may state one.

open now in Medical equipment & pharmaceuticals
10,879
median open notice
€143,348

Who wins in this market

Many suppliers

Germany · Medical equipment & pharmaceuticals

different companies won awards here
809
of the awards went to the three most frequent winners
9%
buyers awarded contracts here
441

Based on 1,512 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
12.2
of those lots received a single tender
16%
of the awards went to companies based in another country
7%
of the tenders came from another country
6%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Similar tenders

Open now

Awarded before

Never miss a tender like this

1,821 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

359 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language